nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—Cisplatin—testicular cancer	0.192	0.391	CbGbCtD
Perindopril—ABCB1—Dactinomycin—testicular cancer	0.0849	0.173	CbGbCtD
Perindopril—ABCB1—Vinblastine—testicular cancer	0.0532	0.108	CbGbCtD
Perindopril—ABCB1—Cisplatin—testicular cancer	0.0488	0.0993	CbGbCtD
Perindopril—ABCB1—Etoposide—testicular cancer	0.0479	0.0975	CbGbCtD
Perindopril—ABCB1—Doxorubicin—testicular cancer	0.0327	0.0665	CbGbCtD
Perindopril—ABCB1—Methotrexate—testicular cancer	0.0316	0.0644	CbGbCtD
Perindopril—ACE—vein—testicular cancer	0.022	0.376	CbGeAlD
Perindopril—ACE—embryo—testicular cancer	0.00416	0.0711	CbGeAlD
Perindopril—ACE—seminal vesicle—testicular cancer	0.00391	0.0668	CbGeAlD
Perindopril—SLC15A2—seminal vesicle—testicular cancer	0.00341	0.0582	CbGeAlD
Perindopril—BCHE—seminal vesicle—testicular cancer	0.00289	0.0493	CbGeAlD
Perindopril—ACE—gonad—testicular cancer	0.00283	0.0483	CbGeAlD
Perindopril—ACE—female gonad—testicular cancer	0.0023	0.0392	CbGeAlD
Perindopril—ACE—testis—testicular cancer	0.00204	0.0348	CbGeAlD
Perindopril—SLC15A2—female gonad—testicular cancer	0.002	0.0342	CbGeAlD
Perindopril—SLC15A2—testis—testicular cancer	0.00178	0.0303	CbGeAlD
Perindopril—BCHE—testis—testicular cancer	0.0015	0.0257	CbGeAlD
Perindopril—ACE—lymph node—testicular cancer	0.00148	0.0252	CbGeAlD
Perindopril—ABCB1—embryo—testicular cancer	0.00147	0.025	CbGeAlD
Perindopril—ABCB1—seminal vesicle—testicular cancer	0.00138	0.0235	CbGeAlD
Perindopril—SLC15A2—lymph node—testicular cancer	0.00129	0.022	CbGeAlD
Perindopril—BCHE—lymph node—testicular cancer	0.00109	0.0186	CbGeAlD
Perindopril—ABCB1—gonad—testicular cancer	0.000995	0.017	CbGeAlD
Perindopril—ABCB1—female gonad—testicular cancer	0.000808	0.0138	CbGeAlD
Perindopril—ABCB1—testis—testicular cancer	0.000717	0.0122	CbGeAlD
Perindopril—ABCB1—lymph node—testicular cancer	0.00052	0.00888	CbGeAlD
Perindopril—Erythema multiforme—Methotrexate—testicular cancer	0.000318	0.000707	CcSEcCtD
Perindopril—Urticaria—Etoposide—testicular cancer	0.000317	0.000704	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—testicular cancer	0.000317	0.000703	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—testicular cancer	0.000317	0.000703	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—testicular cancer	0.000317	0.000703	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—testicular cancer	0.000316	0.000701	CcSEcCtD
Perindopril—Body temperature increased—Etoposide—testicular cancer	0.000316	0.000701	CcSEcCtD
Perindopril—Abdominal pain—Etoposide—testicular cancer	0.000316	0.000701	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—testicular cancer	0.000316	0.000701	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—testicular cancer	0.000316	0.000701	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—testicular cancer	0.000315	0.0007	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—testicular cancer	0.000315	0.0007	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—testicular cancer	0.000315	0.000699	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—testicular cancer	0.000314	0.000697	CcSEcCtD
Perindopril—Asthenia—Cisplatin—testicular cancer	0.000313	0.000694	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—testicular cancer	0.000313	0.000694	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—testicular cancer	0.000312	0.000694	CcSEcCtD
Perindopril—Sweating—Doxorubicin—testicular cancer	0.000311	0.000691	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—testicular cancer	0.000311	0.000691	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—testicular cancer	0.00031	0.000689	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—testicular cancer	0.00031	0.000688	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—testicular cancer	0.000309	0.000686	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000307	0.000682	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—testicular cancer	0.000306	0.00068	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—testicular cancer	0.000305	0.000678	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—testicular cancer	0.000305	0.000677	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—testicular cancer	0.000304	0.000674	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—testicular cancer	0.000303	0.000674	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—testicular cancer	0.000303	0.000673	CcSEcCtD
Perindopril—Chills—Methotrexate—testicular cancer	0.000302	0.000671	CcSEcCtD
Perindopril—Nausea—Ifosfamide—testicular cancer	0.0003	0.000667	CcSEcCtD
Perindopril—Diarrhoea—Cisplatin—testicular cancer	0.000298	0.000662	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—testicular cancer	0.000298	0.000662	CcSEcCtD
Perindopril—Alopecia—Methotrexate—testicular cancer	0.000297	0.000661	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—testicular cancer	0.000297	0.000659	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—testicular cancer	0.000295	0.000655	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—testicular cancer	0.000294	0.000654	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—testicular cancer	0.000294	0.000652	CcSEcCtD
Perindopril—Malnutrition—Methotrexate—testicular cancer	0.000293	0.000651	CcSEcCtD
Perindopril—Erythema—Methotrexate—testicular cancer	0.000293	0.000651	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—testicular cancer	0.000293	0.000651	CcSEcCtD
Perindopril—Flushing—Epirubicin—testicular cancer	0.000292	0.000649	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—testicular cancer	0.000292	0.000649	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—testicular cancer	0.000292	0.000649	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—testicular cancer	0.000292	0.000647	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—testicular cancer	0.000292	0.000647	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—testicular cancer	0.000289	0.000643	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—testicular cancer	0.000288	0.000639	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—testicular cancer	0.000287	0.000638	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—testicular cancer	0.000287	0.000637	CcSEcCtD
Perindopril—Asthenia—Etoposide—testicular cancer	0.000286	0.000636	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—testicular cancer	0.000286	0.000635	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—testicular cancer	0.000286	0.000635	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—testicular cancer	0.000284	0.000631	CcSEcCtD
Perindopril—Back pain—Methotrexate—testicular cancer	0.000283	0.00063	CcSEcCtD
Perindopril—Chills—Epirubicin—testicular cancer	0.000283	0.000628	CcSEcCtD
Perindopril—Pruritus—Etoposide—testicular cancer	0.000283	0.000627	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—testicular cancer	0.000281	0.000625	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—testicular cancer	0.000281	0.000624	CcSEcCtD
Perindopril—Alopecia—Epirubicin—testicular cancer	0.000278	0.000618	CcSEcCtD
Perindopril—Vomiting—Cisplatin—testicular cancer	0.000277	0.000615	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—testicular cancer	0.000276	0.000613	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—testicular cancer	0.000276	0.000612	CcSEcCtD
Perindopril—Rash—Cisplatin—testicular cancer	0.000275	0.00061	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—testicular cancer	0.000275	0.00061	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—testicular cancer	0.000274	0.000609	CcSEcCtD
Perindopril—Erythema—Epirubicin—testicular cancer	0.000274	0.000609	CcSEcCtD
Perindopril—Diarrhoea—Etoposide—testicular cancer	0.000273	0.000607	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—testicular cancer	0.000272	0.000605	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—testicular cancer	0.000272	0.000604	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—testicular cancer	0.000272	0.000604	CcSEcCtD
Perindopril—Anaemia—Methotrexate—testicular cancer	0.000271	0.000602	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—testicular cancer	0.000271	0.000601	CcSEcCtD
Perindopril—Flushing—Doxorubicin—testicular cancer	0.000271	0.000601	CcSEcCtD
Perindopril—Flatulence—Epirubicin—testicular cancer	0.00027	0.0006	CcSEcCtD
Perindopril—Tension—Epirubicin—testicular cancer	0.000269	0.000598	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—testicular cancer	0.000269	0.000596	CcSEcCtD
Perindopril—Nervousness—Epirubicin—testicular cancer	0.000266	0.000592	CcSEcCtD
Perindopril—Back pain—Epirubicin—testicular cancer	0.000265	0.000589	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—testicular cancer	0.000264	0.000587	CcSEcCtD
Perindopril—Malaise—Methotrexate—testicular cancer	0.000264	0.000587	CcSEcCtD
Perindopril—Dizziness—Etoposide—testicular cancer	0.000264	0.000586	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—testicular cancer	0.000264	0.000586	CcSEcCtD
Perindopril—Vertigo—Methotrexate—testicular cancer	0.000263	0.000585	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—testicular cancer	0.000263	0.000583	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—testicular cancer	0.000262	0.000583	CcSEcCtD
Perindopril—Chills—Doxorubicin—testicular cancer	0.000262	0.000581	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—testicular cancer	0.00026	0.000578	CcSEcCtD
Perindopril—Nausea—Cisplatin—testicular cancer	0.000259	0.000575	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—testicular cancer	0.000258	0.000572	CcSEcCtD
Perindopril—Cough—Methotrexate—testicular cancer	0.000256	0.000568	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—testicular cancer	0.000255	0.000567	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—testicular cancer	0.000254	0.000565	CcSEcCtD
Perindopril—Vomiting—Etoposide—testicular cancer	0.000254	0.000564	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—testicular cancer	0.000254	0.000564	CcSEcCtD
Perindopril—Erythema—Doxorubicin—testicular cancer	0.000254	0.000564	CcSEcCtD
Perindopril—Anaemia—Epirubicin—testicular cancer	0.000253	0.000563	CcSEcCtD
Perindopril—Agitation—Epirubicin—testicular cancer	0.000252	0.00056	CcSEcCtD
Perindopril—Rash—Etoposide—testicular cancer	0.000252	0.000559	CcSEcCtD
Perindopril—Dermatitis—Etoposide—testicular cancer	0.000252	0.000559	CcSEcCtD
Perindopril—Headache—Etoposide—testicular cancer	0.00025	0.000556	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—testicular cancer	0.00025	0.000555	CcSEcCtD
Perindopril—Myalgia—Methotrexate—testicular cancer	0.00025	0.000554	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—testicular cancer	0.00025	0.000554	CcSEcCtD
Perindopril—Chest pain—Methotrexate—testicular cancer	0.00025	0.000554	CcSEcCtD
Perindopril—Tension—Doxorubicin—testicular cancer	0.000249	0.000553	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—testicular cancer	0.000249	0.000552	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000248	0.00055	CcSEcCtD
Perindopril—Malaise—Epirubicin—testicular cancer	0.000247	0.000549	CcSEcCtD
Perindopril—Discomfort—Methotrexate—testicular cancer	0.000247	0.000547	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—testicular cancer	0.000246	0.000547	CcSEcCtD
Perindopril—Vertigo—Epirubicin—testicular cancer	0.000246	0.000547	CcSEcCtD
Perindopril—Syncope—Epirubicin—testicular cancer	0.000246	0.000546	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—testicular cancer	0.000245	0.000545	CcSEcCtD
Perindopril—Back pain—Doxorubicin—testicular cancer	0.000245	0.000545	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—testicular cancer	0.000244	0.000542	CcSEcCtD
Perindopril—Palpitations—Epirubicin—testicular cancer	0.000242	0.000538	CcSEcCtD
Perindopril—Confusional state—Methotrexate—testicular cancer	0.000241	0.000536	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—testicular cancer	0.000241	0.000535	CcSEcCtD
Perindopril—Cough—Epirubicin—testicular cancer	0.000239	0.000531	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—testicular cancer	0.000239	0.000531	CcSEcCtD
Perindopril—Nausea—Etoposide—testicular cancer	0.000237	0.000527	CcSEcCtD
Perindopril—Hypertension—Epirubicin—testicular cancer	0.000237	0.000526	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—testicular cancer	0.000235	0.000523	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—testicular cancer	0.000235	0.000521	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—testicular cancer	0.000235	0.000521	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—testicular cancer	0.000234	0.00052	CcSEcCtD
Perindopril—Chest pain—Epirubicin—testicular cancer	0.000233	0.000519	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—testicular cancer	0.000233	0.000519	CcSEcCtD
Perindopril—Myalgia—Epirubicin—testicular cancer	0.000233	0.000519	CcSEcCtD
Perindopril—Agitation—Doxorubicin—testicular cancer	0.000233	0.000518	CcSEcCtD
Perindopril—Anxiety—Epirubicin—testicular cancer	0.000233	0.000517	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—testicular cancer	0.000232	0.000516	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000232	0.000515	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—testicular cancer	0.000231	0.000513	CcSEcCtD
Perindopril—Discomfort—Epirubicin—testicular cancer	0.000231	0.000512	CcSEcCtD
Perindopril—Malaise—Doxorubicin—testicular cancer	0.000229	0.000508	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—testicular cancer	0.000228	0.000507	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—testicular cancer	0.000228	0.000506	CcSEcCtD
Perindopril—Anorexia—Methotrexate—testicular cancer	0.000228	0.000506	CcSEcCtD
Perindopril—Syncope—Doxorubicin—testicular cancer	0.000228	0.000505	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—testicular cancer	0.000227	0.000504	CcSEcCtD
Perindopril—Confusional state—Epirubicin—testicular cancer	0.000226	0.000501	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—testicular cancer	0.000224	0.000498	CcSEcCtD
Perindopril—Oedema—Epirubicin—testicular cancer	0.000224	0.000497	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—testicular cancer	0.000224	0.000497	CcSEcCtD
Perindopril—Hypotension—Methotrexate—testicular cancer	0.000223	0.000496	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—testicular cancer	0.000223	0.000495	CcSEcCtD
Perindopril—Cough—Doxorubicin—testicular cancer	0.000221	0.000492	CcSEcCtD
Perindopril—Shock—Epirubicin—testicular cancer	0.00022	0.000489	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—testicular cancer	0.00022	0.000487	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—testicular cancer	0.000219	0.000487	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—testicular cancer	0.000219	0.000487	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—testicular cancer	0.000218	0.000485	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000218	0.000484	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—testicular cancer	0.000217	0.000483	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—testicular cancer	0.000216	0.000481	CcSEcCtD
Perindopril—Insomnia—Methotrexate—testicular cancer	0.000216	0.00048	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—testicular cancer	0.000216	0.00048	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—testicular cancer	0.000216	0.00048	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—testicular cancer	0.000216	0.00048	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—testicular cancer	0.000215	0.000478	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—testicular cancer	0.000215	0.000477	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000215	0.000476	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—testicular cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Anorexia—Epirubicin—testicular cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—testicular cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Somnolence—Methotrexate—testicular cancer	0.000213	0.000472	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—testicular cancer	0.000211	0.000469	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—testicular cancer	0.000211	0.000468	CcSEcCtD
Perindopril—Hypotension—Epirubicin—testicular cancer	0.000209	0.000464	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—testicular cancer	0.000209	0.000464	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—testicular cancer	0.000208	0.000462	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—testicular cancer	0.000207	0.00046	CcSEcCtD
Perindopril—Oedema—Doxorubicin—testicular cancer	0.000207	0.00046	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000206	0.000459	CcSEcCtD
Perindopril—Fatigue—Methotrexate—testicular cancer	0.000206	0.000458	CcSEcCtD
Perindopril—Pain—Methotrexate—testicular cancer	0.000205	0.000454	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000204	0.000453	CcSEcCtD
Perindopril—Shock—Doxorubicin—testicular cancer	0.000204	0.000453	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—testicular cancer	0.000203	0.000451	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—testicular cancer	0.000203	0.00045	CcSEcCtD
Perindopril—Insomnia—Epirubicin—testicular cancer	0.000202	0.00045	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—testicular cancer	0.000202	0.000449	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—testicular cancer	0.000201	0.000447	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—testicular cancer	0.000201	0.000446	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—testicular cancer	0.0002	0.000445	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—testicular cancer	0.0002	0.000443	CcSEcCtD
Perindopril—Somnolence—Epirubicin—testicular cancer	0.000199	0.000442	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—testicular cancer	0.000197	0.000438	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—testicular cancer	0.000197	0.000438	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—testicular cancer	0.000197	0.000438	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—testicular cancer	0.000196	0.000434	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—testicular cancer	0.000195	0.000432	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—testicular cancer	0.000194	0.00043	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000193	0.000429	CcSEcCtD
Perindopril—Fatigue—Epirubicin—testicular cancer	0.000193	0.000429	CcSEcCtD
Perindopril—Constipation—Epirubicin—testicular cancer	0.000191	0.000425	CcSEcCtD
Perindopril—Pain—Epirubicin—testicular cancer	0.000191	0.000425	CcSEcCtD
Perindopril—Urticaria—Methotrexate—testicular cancer	0.00019	0.000422	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—testicular cancer	0.000189	0.00042	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—testicular cancer	0.000189	0.00042	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000189	0.000419	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—testicular cancer	0.000187	0.000416	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—testicular cancer	0.000186	0.000413	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—testicular cancer	0.000185	0.00041	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—testicular cancer	0.000184	0.00041	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—testicular cancer	0.000184	0.000409	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—testicular cancer	0.000183	0.000406	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—testicular cancer	0.000182	0.000405	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—testicular cancer	0.00018	0.0004	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000179	0.000397	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—testicular cancer	0.000179	0.000397	CcSEcCtD
Perindopril—Urticaria—Epirubicin—testicular cancer	0.000178	0.000395	CcSEcCtD
Perindopril—Pain—Doxorubicin—testicular cancer	0.000177	0.000393	CcSEcCtD
Perindopril—Constipation—Doxorubicin—testicular cancer	0.000177	0.000393	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—testicular cancer	0.000177	0.000393	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—testicular cancer	0.000177	0.000393	CcSEcCtD
Perindopril—Asthenia—Methotrexate—testicular cancer	0.000172	0.000381	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—testicular cancer	0.000171	0.000379	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000169	0.000376	CcSEcCtD
Perindopril—Pruritus—Methotrexate—testicular cancer	0.000169	0.000376	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—testicular cancer	0.000165	0.000365	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—testicular cancer	0.000164	0.000364	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—testicular cancer	0.000164	0.000364	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—testicular cancer	0.000164	0.000363	CcSEcCtD
Perindopril—Asthenia—Epirubicin—testicular cancer	0.000161	0.000357	CcSEcCtD
Perindopril—Pruritus—Epirubicin—testicular cancer	0.000158	0.000352	CcSEcCtD
Perindopril—Dizziness—Methotrexate—testicular cancer	0.000158	0.000351	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—testicular cancer	0.000153	0.00034	CcSEcCtD
Perindopril—Vomiting—Methotrexate—testicular cancer	0.000152	0.000338	CcSEcCtD
Perindopril—Rash—Methotrexate—testicular cancer	0.000151	0.000335	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—testicular cancer	0.000151	0.000335	CcSEcCtD
Perindopril—Headache—Methotrexate—testicular cancer	0.00015	0.000333	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—testicular cancer	0.000149	0.00033	CcSEcCtD
Perindopril—Dizziness—Epirubicin—testicular cancer	0.000148	0.000329	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—testicular cancer	0.000147	0.000325	CcSEcCtD
Perindopril—Vomiting—Epirubicin—testicular cancer	0.000142	0.000316	CcSEcCtD
Perindopril—Nausea—Methotrexate—testicular cancer	0.000142	0.000316	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—testicular cancer	0.000142	0.000315	CcSEcCtD
Perindopril—Rash—Epirubicin—testicular cancer	0.000141	0.000313	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—testicular cancer	0.000141	0.000313	CcSEcCtD
Perindopril—Headache—Epirubicin—testicular cancer	0.00014	0.000311	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—testicular cancer	0.000137	0.000304	CcSEcCtD
Perindopril—Nausea—Epirubicin—testicular cancer	0.000133	0.000295	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—testicular cancer	0.000132	0.000292	CcSEcCtD
Perindopril—Rash—Doxorubicin—testicular cancer	0.000131	0.00029	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—testicular cancer	0.00013	0.00029	CcSEcCtD
Perindopril—Headache—Doxorubicin—testicular cancer	0.00013	0.000288	CcSEcCtD
Perindopril—Nausea—Doxorubicin—testicular cancer	0.000123	0.000273	CcSEcCtD
